Market Place
Sourcing Support
7 Hills Pharma Begins Phase 1b/2a Trial for aPD-1-resistant Tumors
03 Sep 2024 //
GLOBENEWSWIRE
7 Hills Gets $4.7MM For First-In-Class Cell/Gene Therapy
03 Jun 2024 //
GLOBENEWSWIRE
7 Hills Pharma Surpasses $25MM Milestone in Nondilutive Funding
22 May 2023 //
GLOBENEWSWIRE
7 Hills Pharma Receives $3MM SBIR Grant from NIAID
01 Aug 2022 //
GLOBENEWSWIRE
7 Hills Pharma Expands Pioneering Patent Portfolio
09 Jun 2022 //
GLOBENEWSWIRE
Integrin Activation Can Bring the Heat to Cold Melanoma Tumors
18 May 2022 //
GLOBENEWSWIRE
7 Hills Pharma`s 7HP349 Granted FDA FTD for Anti-PD-1-resistant MM
08 Mar 2022 //
GLOBENEWSWIRE
7 Hills Pharma Announces the Completion of a Landmark Phase I Trial
01 Nov 2021 //
GLOBENEWSWIRE
7 Hills Pharma Announces First Healthy Volunteers Dosed in Landmark Ph1 Trial
09 Nov 2020 //
GLOBENEWSWIRE
7 Hills Pharma Awarded Pioneering Patent Estate Covering Integrin Activators
04 Aug 2020 //
GLOBENEWSWIRE
7 Hills Pharma Announces Positive Data With Oral Immunostimulant
07 Jul 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.